Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes

Por Shen, Ding-Wu, Pouliot, Lynn M., Hall, Matthew D., Gottesman, Michael M.
Publicado em 2012

Contributions of microRNA Dysregulation to Cisplatin Resistance in Adenocarcinoma Cells

Por Pouliot, Lynn M., Shen, Ding-Wu, Suzuki, Toshihiro, Hall, Matthew D., Gottesman, Michael M.
Publicado em 2012

Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family

Por Pouliot, Lynn M., Chen, Yu-Chi, Bai, Jennifer, Guha, Rajarshi, Martin, Scott E., Gottesman, Michael M., Hall, Matthew D.
Publicado em 2012

The Transcription Factor GCF2 is an Upstream Repressor of the Small GTPAse RhoA, Regulating Membrane Protein Trafficking, Sensitivity to Doxorubicin and Resistance to Cisplatin

Por Shen, Ding-Wu, Pouliot, Lynn M., Gillet, Jean-Pierre, Ma, Wenting, Johnson, Alfred C., Hall, Matthew D., Gottesman, Michael M.
Publicado em 2012

Uptake of Compounds That Selectively Kill Multidrug-Resistant Cells: The Copper Transporter SLC31A1 (CTR1) Increases Cellular Accumulation of the Thiosemicarbazone NSC73306

Por Fung, King Leung, Tepede, Abisola K., Pluchino, Kristen M., Pouliot, Lynn M., Pixley, Jessica N., Hall, Matthew D., Gottesman, Michael M.
Publicado em 2014